Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
221.67K | 498.92K | 2.99M | 2.68M | 1.60M | 890.15K | Gross Profit |
-6.67M | -4.64M | -3.05M | -2.09M | -166.48K | 198.31K | EBIT |
-20.95M | -28.16M | -23.28M | -33.13M | -10.11M | -8.49M | EBITDA |
-20.30M | -26.92M | -21.98M | -32.34M | -9.88M | -7.77M | Net Income Common Stockholders |
-6.27M | -34.16M | -45.87M | -33.13M | -11.33M | -8.84M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
39.24K | 33.44M | 48.95M | 69.16M | 36.54M | 641.82K | Total Assets |
3.24M | 52.86M | 54.99M | 78.13M | 41.96M | 2.78M | Total Debt |
34.95K | 699.51K | 859.54K | 1.07M | 1.15M | 1.32M | Net Debt |
-4.30K | -32.74M | -38.24M | -68.09M | -35.39M | 683.15K | Total Liabilities |
3.13M | 27.53M | 2.93M | 4.70M | 2.60M | 2.71M | Stockholders Equity |
108.39K | 25.33M | 52.06M | 73.42M | 39.36M | 68.94K |
Cash Flow | Free Cash Flow | ||||
-15.45M | -28.37M | -20.37M | -27.23M | -10.54M | -4.61M | Operating Cash Flow |
-15.21M | -26.18M | -18.73M | -26.63M | -10.02M | -4.10M | Investing Cash Flow |
19.78M | 8.89M | -11.34M | -600.36K | 2.54M | -374.35K | Financing Cash Flow |
15.70M | 21.63M | 0.00 | 59.86M | 43.37M | 5.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
59 Neutral | $12.41B | 10.34 | 1.32% | 3.61% | 1.65% | -18.04% | |
48 Neutral | $135.41M | ― | -1.59% | ― | -11.61% | -22.20% | |
43 Neutral | $14.95M | ― | -157.31% | ― | -25.03% | 42.78% | |
43 Neutral | $10.15B | ― | -155.53% | ― | 13.77% | 17.85% | |
40 Underperform | $1.88M | ― | -72.67% | ― | 258.96% | 82.54% | |
36 Underperform | $3.45M | ― | -21.91% | ― | -76.66% | 47.08% |
AYRO held its Annual Meeting on December 30, 2024, where several proposals were presented and approved by stockholders. These included the election of six directors, an amendment to the Long-Term Incentive Plan to increase shares, ratification of Marcum LLP as the independent accounting firm, a reverse stock split, and a proposal to adjourn the meeting if needed. The approval of these proposals is expected to impact the company’s operational framework and strategic direction, potentially affecting its market positioning and stakeholder interests.
AYRO, Inc. has amended its Securities Purchase Agreement with investors, affecting its Series H-7 Convertible Preferred Stock and related warrants. A new amendment has been agreed upon with required holders, classifying Director Equity Grants as ‘Excluded Securities.’ The company’s board approved stock and cash-settled restricted stock unit awards to directors, based on a $0.76 share price, as part of annual and partial annual grants for 2023 and 2024.